Influenza A virus H5N1 vaccine - Solvay

Drug Profile

Influenza A virus H5N1 vaccine - Solvay

Alternative Names: Pandemic H5N1 egg-based vaccine - Solvay

Latest Information Update: 03 Jun 2009

Price : $50

At a glance

  • Originator Solvay Pharmaceuticals
  • Class Influenza A virus H5N1 vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Influenza A virus H5N1 subtype

Most Recent Events

No Data Available
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top